Cargando…

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma

PURPOSE: Gliomas are the most frequent primary brain tumors of adults. Despite intensive research, there are still no targeted therapies available. Here, we performed an integrated analysis of glioma and programmed cell death ligand 1 (PD-L1) in 90 samples including 58 glioma and 32 control brain ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hölzl, Dorothee, Hutarew, Georg, Zellinger, Barbara, Schlicker, Hans U., Schwartz, Christoph, Winkler, Peter A., Sotlar, Karl, Kraus, Theo F. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236471/ https://www.ncbi.nlm.nih.gov/pubmed/33963441 http://dx.doi.org/10.1007/s00432-021-03656-w

Ejemplares similares

EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling
por: Hölzl, Dorothee, et al.
Publicado: (2022)

Dissecting the Methylomes of EGFR-Amplified Glioblastoma Reveals Altered DNA Replication and Packaging, and Chromatin and Gene Silencing Pathways
por: Kraus, Theo F. J., et al.
Publicado: (2023)

A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature
por: Kraus, Theo F. J., et al.
Publicado: (2022)

Methylome Profiling of PD-L1-Expressing Glioblastomas Shows Enrichment of Post-Transcriptional and RNA-Associated Gene Regulation
por: Hutarew, Georg, et al.
Publicado: (2022)

Diffuse midline glioma of the cervical spinal cord with H3 K27M genotype phenotypically mimicking anaplastic ganglioglioma: a case report and review of the literature
por: Kraus, Theo F. J., et al.
Publicado: (2020)

Genotypical glioblastoma of the frontal lobe mimicking ganglioglioma: A case report and review of the literature
por: Kraus, Theo F. J., et al.
Publicado: (2021)

Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma
por: Lin, Han, et al.
Publicado: (2021)

Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis
por: Li, Xiao-Song, et al.
Publicado: (2020)

Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells
por: Liu, Jingjing, et al.
Publicado: (2019)

An autophagic gene‐based signature to predict the survival of patients with low‐grade gliomas
por: Chen, Jian, et al.
Publicado: (2021)

Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
por: Miglietta, Federica, et al.
Publicado: (2019)

Aggressiveness of care at end of life in patients with high‐grade glioma
por: Harrison, Rebecca A., et al.
Publicado: (2021)

Programmed death‐ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2‐negative status
por: Wang, Lei, et al.
Publicado: (2018)

On high‐risk, low‐grade glioma: What distinguishes high from low?
por: Geurts, Marjolein, et al.
Publicado: (2018)

Differences in the preferential location and invasiveness of diffuse low‐grade gliomas and their impact on outcome
por: Latini, Francesco, et al.
Publicado: (2020)

Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin‐specific peptidase 9, X‐linked in oral squamous cell carcinoma
por: Jingjing, Wu, et al.
Publicado: (2018)

Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy
por: Marcq, Gautier, et al.
Publicado: (2022)

Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019)

Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations
por: Häggström, Christel, et al.
Publicado: (2014)

B7‐1 and programmed cell death‐ligand 1 in primary and lymph node metastasis lesions of non‐small cell lung carcinoma
por: Yamada, Takehiro, et al.
Publicado: (2021)

Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV
por: McDuff, Susan G. R., et al.
Publicado: (2019)

Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma
por: Robinson, M Hope, et al.
Publicado: (2020)

The prognostic impact of programmed cell death 1 and its ligand and the correlation with epithelial‐mesenchymal transition in thymic carcinoma
por: Funaki, Soichiro, et al.
Publicado: (2019)

The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer
por: Imai, Daisuke, et al.
Publicado: (2017)

Daratumumab prevents programmed death ligand‐1 expression on antigen‐presenting cells in de novo multiple myeloma
por: Stocker, Nicolas, et al.
Publicado: (2020)

Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma
por: Patil, Vijay M., et al.
Publicado: (2020)

A germline PALB2 pathogenic variant identified in a pediatric high-grade glioma
por: Zhong, Yiming, et al.
Publicado: (2020)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020)

Effects of the MAML2 genetic variants in glioma susceptibility and prognosis
por: Zhang, Ming, et al.
Publicado: (2019)

Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors
por: Engelhardt, Sophie, et al.
Publicado: (2022)

Epithelial‐mesenchymal transition‐converted tumor cells can induce T‐cell apoptosis through upregulation of programmed death ligand 1 expression in esophageal squamous cell carcinoma
por: Thar Min, Aung Kyi, et al.
Publicado: (2018)

Outcomes of Patients with Advanced Urothelial Carcinoma after Anti–programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational Study
por: Rezazadeh Kalebasty, Arash, et al.
Publicado: (2022)

Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma
por: Aragon-Sanabria, Virginia, et al.
Publicado: (2022)

FAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma
por: Madan, Evanka, et al.
Publicado: (2016)

BCR-NTRK2 fusion in a low-grade glioma with distinctive morphology and unexpected aggressive behavior
por: Jones, Karra A., et al.
Publicado: (2019)

PD-L1 testing, fit for routine evaluation? From a pathologist’s point of view
por: Hutarew, Georg
Publicado: (2016)

Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”
por: Hou, Chongxian, et al.
Publicado: (2020)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients
por: Chen, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_62ltblqgok9ogf2ucv3pblkaqv